Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene: A positron emission tomography study




Tuunanen H, Kuusisto J, Toikka J, Jaaskelaeinen P, Marjamaki P, Peuhkurinen K, Viljanen T, Sipola P, Stolen KQ, Hannukainen J, Nuutila P, Laakso M, Knuuti J

PublisherMOSBY-ELSEVIER

2007

Journal of Nuclear Cardiology

JOURNAL OF NUCLEAR CARDIOLOGY

J NUCL CARDIOL

14

3

354

365

12

1071-3581

DOIhttps://doi.org/10.1016/j.nuclcard.2006.12.329



Conclusions. In HCM attributable to the Asp175Asn mutation in the a-tropomyosin gene, myocardial oxidative metabolism and FFA metabolism are increased and inversely related to LV hypertrophy at both the whole heart and regional level. Increased metabolism and efficiency characterize patients with mild myocardial hypertrophy. These hypermetabolic alterations regress with advanced hypertrophy.




Last updated on 2024-26-11 at 21:44